Alex Mann

1.0k total citations
24 papers, 660 citations indexed

About

Alex Mann is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Alex Mann has authored 24 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Alex Mann's work include Influenza Virus Research Studies (11 papers), Respiratory viral infections research (9 papers) and Viral gastroenteritis research and epidemiology (4 papers). Alex Mann is often cited by papers focused on Influenza Virus Research Studies (11 papers), Respiratory viral infections research (9 papers) and Viral gastroenteritis research and epidemiology (4 papers). Alex Mann collaborates with scholars based in United Kingdom, United States and Israel. Alex Mann's co-authors include Rob Lambkin‐Williams, John Oxford, Anthony Gilbert, Tom Wilkinson, John P. DeVincenzo, Andrew Catchpole, Saraswathy V. Nochur, Lisa M. Harrison, Rachel Meyers and Jeff Cehelsky and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Alex Mann

22 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex Mann United Kingdom 10 456 239 153 127 117 24 660
Youri Lee United States 19 475 1.0× 333 1.4× 85 0.6× 287 2.3× 135 1.2× 47 820
Rajagowthamee R. Thangavel United States 5 263 0.6× 82 0.3× 74 0.5× 123 1.0× 171 1.5× 6 575
Gerry Harnett Australia 11 357 0.8× 58 0.2× 57 0.4× 31 0.2× 58 0.5× 13 529
Ryan P. Gilley United States 13 339 0.7× 96 0.4× 87 0.6× 247 1.9× 366 3.1× 16 773
Jinlong Zhang China 11 108 0.2× 320 1.3× 38 0.2× 70 0.6× 137 1.2× 39 615
Yuko Yamaguchi United Kingdom 14 292 0.6× 147 0.6× 141 0.9× 178 1.4× 71 0.6× 28 611
Aude Rémot France 12 205 0.4× 168 0.7× 145 0.9× 132 1.0× 264 2.3× 25 664
Laura Lindholm Finland 13 155 0.3× 209 0.9× 35 0.2× 42 0.3× 142 1.2× 19 520
Birgit Thierry-Carstensen Denmark 10 284 0.6× 317 1.3× 26 0.2× 299 2.4× 108 0.9× 15 655
Herbert Van Kruiningen United States 6 341 0.7× 317 1.3× 47 0.3× 94 0.7× 280 2.4× 6 793

Countries citing papers authored by Alex Mann

Since Specialization
Citations

This map shows the geographic impact of Alex Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Mann more than expected).

Fields of papers citing papers by Alex Mann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Mann. The network helps show where Alex Mann may publish in the future.

Co-authorship network of co-authors of Alex Mann

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Mann. A scholar is included among the top collaborators of Alex Mann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Mann. Alex Mann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pauly, Matthew D., David VanInsberghe, Shamika Danzy, et al.. (2026). Within-host adaptive evolution is limited by genetic drift in experimental human influenza A virus infections. bioRxiv (Cold Spring Harbor Laboratory). 1 indexed citations
2.
Schmöele-Thoma, Beate, Agnieszka Zareba, Qin Jiang, et al.. (2022). Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study. New England Journal of Medicine. 386(25). 2377–2386. 79 indexed citations
3.
Bekeredjian‐Ding, Isabelle, Jean‐Hugues Trouvin, Hilde Depraetere, et al.. (2021). Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain. Biologicals. 74. 16–23. 3 indexed citations
5.
Ghebre, Michael A., et al.. (2019). Late Breaking Abstract - A key endpoint in viral challenge models of asthma exacerbations. PA347–PA347. 1 indexed citations
6.
Lambkin‐Williams, Rob, Nicolas Noulin, Alex Mann, Andrew Catchpole, & Anthony Gilbert. (2018). The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics. Respiratory Research. 19(1). 123–123. 43 indexed citations
7.
Catchpole, Andrew, et al.. (2018). The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process. BMC Research Notes. 11(1). 620–620. 6 indexed citations
9.
Ramos‐Sevillano, Elisa, William G. Wade, Alex Mann, et al.. (2018). The Effect of Influenza Virus on the Human Oropharyngeal Microbiome. Clinical Infectious Diseases. 68(12). 1993–2002. 33 indexed citations
12.
Bagga, Bindiya, Christopher W. Woods, Timothy Veldman, et al.. (2013). Comparing Influenza and Rsv Viral and Disease Dynamics in Experimentally Infected Adults Predicts Clinical Effectiveness of Rsv Antivirals. Antiviral Therapy. 18(6). 785–792. 52 indexed citations
13.
Colman, Jonathan E., Diress Tsegaye, Christian Pedersen, et al.. (2012). Behavioral Interference Between Sympatric Reindeer and Domesticated Sheep in Norway. Rangeland Ecology & Management. 65(3). 299–308. 5 indexed citations
14.
Wilkinson, Tom, Olga Pleguezuelos, Stuart Robinson, et al.. (2012). Induction of protective T cell immunity against influenza using a novel peptide vaccine. 40. 2534. 2 indexed citations
15.
Joseph, Aviva, Sarit Samira, Hagit Eliyahu, et al.. (2011). A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity. Vaccine. 29(13). 2474–2486. 38 indexed citations
16.
DeVincenzo, John P., Tom Wilkinson, Akshay Vaishnaw, et al.. (2010). Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus. American Journal of Respiratory and Critical Care Medicine. 182(10). 1305–1314. 237 indexed citations
17.
Mann, Alex, et al.. (2008). Does Survey Medium Affect Responses? An Exploration of Electronic and Paper Surveying in British Colombia Schools.. 6(7). 5 indexed citations
18.
Mett, Vadim, Konstantin Musiychuk, Hong Bi, et al.. (2008). A plant‐produced influenza subunit vaccine protects ferrets against virus challenge. Influenza and Other Respiratory Viruses. 2(1). 33–40. 62 indexed citations
19.
Oxford, John, Rob Lambkin‐Williams, & Alex Mann. (2007). The Threat of Avian Influenza H5N1: ‘Do We Have the Tools for the Job?’. Antiviral chemistry & chemotherapy. 18(2). 71–74. 1 indexed citations
20.
Lambkin‐Williams, Rob, John Oxford, Alex Mann, et al.. (2004). Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine. Vaccine. 22(31-32). 4390–4396. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026